股骨髋臼撞击症伴或不伴股骨髋臼外侧缘发育不良患者髋关节镜术后至少5年随访的生存率与患者报告结局
该队列研究对连续接受髋关节镜股骨髋臼撞击症(FAI)矫正术且外侧缘发育不良(LCEA 13°-25°)的75例患者进行前瞻性随访,并与120例年龄性别匹配、LCEA>25°的FAI对照比较。发育不良组5年生存率97%,两组生存率及所有患者报告结局评分均无统计学差异;发育不良组女性亚组生存率78% vs 男性100%(P<.001),5年UCLA评分女性6分 vs 男性10分(P=.003)。作者认为髋关节镜是伴外侧缘发育不良FAI的成功治疗选择,无论发育不良严重程度,患者可期待与正常股骨头覆盖者相似的改善。
要点
- 发育不良组5年生存率97%,与LCEA>25°对照组在生存率及所有PROM评分上均无统计学差异(P>.05)。
- 发育不良组女性亚组生存率78% vs 男性100%(P<.001),5年UCLA评分女性6分 vs 男性10分(P=.003)。
- 按发育不良严重程度分层,严重发育不良(LCEA<20°,n=11)与临界发育不良(LCEA 20°-25°,n=64)在生存率或结局上无差异。
核心结论
- 作者认为,在中短期随访中,髋关节镜干预是伴外侧缘发育不良的FAI的成功治疗选择。
- 无论发育不良严重程度如何,患者可期待与正常股骨头覆盖患者相似的改善。
研究设计与样本
- 队列研究,证据等级3级。
- 前瞻性收集连续接受髋关节镜FAI矫正术且外侧缘发育不良(LCEA 13°-25°)患者的结局数据(N=75例)。
- 另设年龄和性别匹配的120例对照(LCEA>25°)。
- 生存率定义为避免全髋关节置换,采用Kaplan-Meier曲线及log-rank检验评估。
- 发育不良组独立分析,采用回归分析识别可能提示较差结局的因素,并分为临界发育不良(LCEA 20°-25°)和严重发育不良(LCEA<20°)两个亚组。
主要发现
- 发育不良组生存率为97%。
- 两组间生存率及所有PROM评分均无统计学差异(P>.05)。
- 两组在mHHS、UCLA和WOMAC达到MCID的比例相似;FAI对照组SF-36达到MCID的比例更高(P=.012;效应量=0.274[小])。
- 发育不良组女性(n=9)生存率78% vs 发育不良组男性(n=66)100%(P<.001);发育不良组女性5年UCLA评分6分 vs 发育不良组男性10分(P=.003;效应量=0.378[中]),其他结局在性别间无差异。
- 回归分析未识别出能准确预测发育不良组较差结局的变量;严重发育不良(LCEA<20°,n=11)与临界发育不良(LCEA 20°-25°,n=64)在生存率或结局上无差异。
关键数值与推荐
- 发育不良组LCEA为13°-25°;对照组LCEA>25°。
- 临界发育不良定义为LCEA 20°-25°;严重发育不良定义为LCEA<20°。
- 发育不良组生存率97%;女性亚组生存率78% vs 男性亚组100%(P<.001)。
- 5年UCLA评分:发育不良组女性6分 vs 发育不良组男性10分(P=.003;效应量=0.378[中])。
- SF-36达到MCID的比例:FAI对照组高于发育不良组(P=.012;效应量=0.274[小])。
临床怎么用
- 作者认为髋关节镜干预是伴外侧缘发育不良FAI在中短期随访中的成功治疗选择。
- 作者认为无论发育不良严重程度如何,患者可期待与正常股骨头覆盖患者相似的改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Femoroacetabular impingement (FAI) in patients with dysplasia presents a unique challenge to surgeons. Short-term outcomes are conflicting, while longer term follow-up data are only emerging. PURPOSE: To quantify midterm (minimum 5-year follow-up) outcomes after the arthroscopic correction of FAI in the presence of lateral rim dysplasia compared with a matched control group with FAI with normal acetabular coverage. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Prospective outcome data, collected in a consecutive series of patients undergoing arthroscopic FAI correction with lateral rim dysplasia (lateral center-edge angle [LCEA] of 13°-25°), were reviewed (N = 75 cases). An age- and sex-matched control group of 120 cases was also formed (LCEA >25°). Survivorship was defined as the avoidance of total hip replacement and assessed using a Kaplan-Meier curve with the log-rank test. Survival rates and patient-reported outcome measure (PROM) scores (modified Harris Hip Score [mHHS], University of California, Los Angeles [UCLA], 36-Item Short Form Health Survey [SF-36], and Western Ontario and McMaster Universities Osteoarthritis Index [WOMAC] preoperatively and at 5 years postoperatively) were compared between the groups. The proportion of patients across groups achieving the minimal clinically important difference (MCID) was compared for each PROM. The dysplasia group was also analyzed independently to identify any factors that may indicate a less favorable outcome using regression analysis. The group was divided into 2 subgroups: borderline dysplasia (LCEA of 20°-25°) and severe dysplasia (LCEA <20°). RESULTS: The survival rate in the dysplasia group was 97%. There was no statistical difference with respect to survival rates or any PROM scores (P > .05 for all) between the groups. There were similar rates of achieving the MCID between the groups for the mHHS, UCLA, and WOMAC. The FAI control group had a higher rate of achieving the MCID for the SF-36 (P = .012; effect size = 0.274 [small]). Subgroup analysis indicated a lower survival rate (78% vs 100%, respectively; P < .001) in female cases in the dysplasia group (n = 9) compared with male cases in the dysplasia group (n = 66). The UCLA score in female cases in the dysplasia group at 5 years was statistically lower compared with that in male cases in the dysplasia group (6 vs 10, respectively; P = .003; effect size = 0.378 [medium]), but no other outcome revealed any differences between the sexes. There were also no variables identified on regression analysis that accurately predicted a poorer outcome in the dysplasia group. When stratified by severity, there was no difference in survivorship or outcomes between those with severe dysplasia (LCEA <20°; n = 11) and those with borderline dysplasia (LCEA of 20°-25°; n = 64). CONCLUSION: An arthroscopic intervention was a successful treatment option for FAI in the presence of lateral rim dysplasia at midterm follow-up. Irrespective of the severity of dysplasia, patients can expect similar improvements to those in patients with normal femoral head coverage.
引用
- Mullins K, Filan D, Carton P, et al. High Survivorship and Comparable Patient-Reported Outcomes at a Minimum 5 Years After Hip Arthroscopic Surgery in Patients With Femoroacetabular Impingement, With and Without Lateral Rim Dysplasia. Am J Sports Med. 2023. PMID: 36688631. doi:10.1177/03635465221145018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。